Posts by: Marisa Wexler

News

Xeljanz (tofacitinib) might be an effective and safe treatment for children with systemic juvenile idiopathic arthritis (JIA), a new case report suggests. The study, “Tofacitinib Treatment of Refractory Systemic Juvenile ... Read more

March 19, 2019

Machine Learning Used to Identify Changes in Immune System in JIA Patients, Study Reports

News

Researchers have used machine learning to identify changes to the immune system associated with juvenile idiopathic arthritis (JIA). Understanding these changes may lead to better diagnosis and treatment options ... Read more

Posts by: Marisa Wexler

Marisa Wexler

Case Report Supports Use of Xeljanz in Children with Systemic JIA

Machine Learning Used to Identify Changes in Immune System in JIA Patients, Study Reports

Pin It on Pinterest